摘要
目的探讨灯盏花素注射液对重症胰腺炎(Acutenecrosispancreatitis,SP)的治疗作用,以提高重症胰腺炎的疗效。方法把40例重症胰腺炎进行分组,治疗组25例,对照组15例进行前瞻性研究。治疗组、对照组所有SP患者均先行急诊手术治疗,术后按常规处理,其中治疗组术后加用灯盏花素注射液。结果两组的临床表现、检验、手术和病理和并发症无显著性差异,有可比性。治疗组的病死率为8.0%,对照组病死率40.6%,差异有显著性(P<0.05)。治疗组红细胞压积从术前的44.8±5.1%降低到31.5±3.4%,其差异有显著性(P<0.05)。而血小板和血红蛋白的变化无统计学差异。结论对重症胰腺炎的治疗应以循证医学为依据,灯盏花素在以手术为主的中西医结合治疗SP中有重要的临床价值。
Objective To investigate the effect of breviscapine in serve pancreatitis and to improve the curative effect in SP.Methods 40 patients were divided into two groups: Except the trial group (25 patients) was injected with breviscapine postoperatively,the other therapies were as same as that of the control group(15 patients).and both the clinical manifestation,lab test,operation,pathological report and complication have no statistical significance.Results the mortality(8.0%) of the trial group was significantly lower than that(40.6%) or the control group(P<0.05),and its Hematocrit was obvious decreased from 44.8±5.2 to 31.5±3.4%(P<0.05).but platelet and hemoglobin showed no statistical significance.Conclusion the modern treatment to SP is based upon its evidence of medicine, breviscapine is very important to treat with SP combined with classical methods.
出处
《中国实用医药》
2006年第4期11-12,共2页
China Practical Medicine
关键词
灯盏花素
重症胰腺炎
breviscapine
serve pancreatitis
